Castle biosciences reports fourth quarter and full-year 2023 results

Friendswood, texas--(business wire)--castle biosciences, inc. (nasdaq: cstl), a company improving health through innovative tests that guide patient care, today announced its financial results for the fourth quarter and year ended dec. 31, 2023. “2023 was another exceptional year, with strong top-line growth and test report volume growth, driven in large part by consistent execution by the entire castle team,” said derek maetzold, president and chief executive officer of castle biosciences. “i.
CSTL Ratings Summary
CSTL Quant Ranking